HCW Biologics Inc Earnings

The next earnings date for HCW Biologics Inc has not yet been scheduled.

Analyst Estimates of HCW Biologics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

HCW Biologics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/18/2024---$-0.10---
08/15/2024---$-0.40---
05/15/2024After Market$-0.30-114.29%
03/26/2024---$-0.30-106.90%
11/14/2023Before Market$-0.14-7.69%
08/11/2023Before Market$-0.1220.00%
05/09/2023Before Market$-0.140.00%
03/28/2023After Market$-0.156.25%
11/07/2022After Market$-0.118.33%
08/12/2022Before Market$-0.1016.67%
05/13/2022Before Market$-0.0645.45%
03/29/2022Before Market$-0.17-41.67%
11/12/2021Before Market$-0.08---
08/13/2021Before Market$-0.20---
06/30/2021---$-0.66---
03/31/2021---$-0.69---
09/30/2020---$-0.63---
06/30/2020---$-0.65---
03/31/2020---$-0.56---

More About HCW Biologics Inc

Country
USA
Full Time Employees
36

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

HCW Biologics Inc Earnings” Can Refer to the HCW Biologics Inc Earnings Date

Some people say “HCW Biologics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my HCW Biologics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning HCW Biologics Inc Stock on the Earnings Date

If you own HCW Biologics Inc stock (HCWB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for HCW Biologics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading HCW Biologics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More HCW Biologics Inc Earnings

You can contact us any time if you would like to ask questions about HCW Biologics Inc earnings or anything else related to the stock market.